High-density lipoprotein quantity or quality for cardiovascular prevention?
- PMID: 20196739
- DOI: 10.2174/138161210791050960
High-density lipoprotein quantity or quality for cardiovascular prevention?
Abstract
Plasma concentrations of HDL cholesterol (HDL-C) are strongly and inversely associated with cardiovascular risk, leading to the concept that therapies to enhance plasma HDL-C levels would be anti-atherogenic and protective against cardiovascular events. However, HDL are highly heterogeneous, with subclasses that can be separated and identified according to density, size, charge, and protein composition. There is evidence that these subclasses may differ in their functional anti-atherogenic properties. As a snapshot of the steady-state cholesterol carried by all HDL subclasses together, the individual HDL-C measurement is insufficient to capture the structural and functional variation in HDL particles. This review addresses the current knowledge on the structural and functional heterogeneity of HDL particles, and their relationship to cardiovascular disease, in the attempt of answering the question on whether certain subclasses of HDL may be better predictors of cardiovascular risk than HDL-C, and may be better targets than HDL-C for further improving cardiovascular disease reduction in the statin era.
Similar articles
-
Genetic determinants of HDL metabolism.Curr Med Chem. 2014;21(25):2855-63. doi: 10.2174/0929867321666140303154452. Curr Med Chem. 2014. PMID: 24606513 Review.
-
Health benefits of high-density lipoproteins in preventing cardiovascular diseases.J Clin Lipidol. 2012 Nov-Dec;6(6):524-33. doi: 10.1016/j.jacl.2012.04.004. Epub 2012 Apr 13. J Clin Lipidol. 2012. PMID: 23312048 Review.
-
[Laboratory assessment of HDL heterogeneity and function].Ann Biol Clin (Paris). 2009 Jan-Feb;67(1):7-21. doi: 10.1684/abc.2008.0284. Ann Biol Clin (Paris). 2009. PMID: 19189882 Review. French.
-
Laboratory assessment of HDL heterogeneity and function.Clin Chem. 2008 May;54(5):788-800. doi: 10.1373/clinchem.2007.101923. Epub 2008 Mar 28. Clin Chem. 2008. PMID: 18375481 Review.
-
Physiological role and clinical relevance of high-density lipoprotein subclasses.Curr Opin Lipidol. 1994 Dec;5(6):404-16. doi: 10.1097/00041433-199412000-00003. Curr Opin Lipidol. 1994. PMID: 7712045 Review.
Cited by
-
Association Between HDL2-C and HDL3-C with Cardiovascular Disease: A Nested Case-Control Study in an Iranian Population.Int J Endocrinol Metab. 2023 Dec 30;22(1):e141550. doi: 10.5812/ijem-141550. eCollection 2024 Jan. Int J Endocrinol Metab. 2023. PMID: 38665147 Free PMC article.
-
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production.Diabetes Ther. 2024 Jan;15(1):257-268. doi: 10.1007/s13300-023-01491-5. Epub 2023 Oct 26. Diabetes Ther. 2024. PMID: 37883003 Free PMC article.
-
HDL and chronic kidney disease.Atheroscler Plus. 2023 Apr 18;52:9-17. doi: 10.1016/j.athplu.2023.04.001. eCollection 2023 Jun. Atheroscler Plus. 2023. PMID: 37193017 Free PMC article.
-
Air Pollution: Another Threat to HDL Function.Int J Mol Sci. 2022 Dec 24;24(1):317. doi: 10.3390/ijms24010317. Int J Mol Sci. 2022. PMID: 36613760 Free PMC article. Review.
-
Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.Diabetologia. 2021 Aug;64(8):1834-1849. doi: 10.1007/s00125-021-05498-0. Epub 2021 Jun 16. Diabetologia. 2021. PMID: 34131781 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials